The present demonstration that long-term treatment with CsA ameliorates performance in specific muscles of 5 out 6 UCMD patients and improves regeneration is an encouraging result that raises some hope for the use of cyclophilin inhibitors for the cure of this and possibly other muscle diseases. The gene discussed is PPIB; the disease is Congenital muscular dystrophy, Ullrich type.